Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Apr;35(2):158-65.
doi: 10.1007/s12020-008-9144-0. Epub 2009 Jan 24.

In hyperthyroid rats octylguanidine protects the heart from reperfusion damage

Affiliations

In hyperthyroid rats octylguanidine protects the heart from reperfusion damage

Natalia Pavón et al. Endocrine. 2009 Apr.

Abstract

Hyperthyroidism sensitizes the heart for reperfusion injury. As known, mitochondrial permeability transition underlies reperfusion heart damage. This study was undertaken to explore the protective effect of octylguanidine (OG), an inhibitor of permeability transition, on hearts from hyperthyroid rats subjected to ischemia/reperfusion. Hyperthyroidism was induced by a daily injection of 2 mg T3/kg body weight for 5 days. OG was injected at a dose of 5 mg/kg body weight. It was found that the amine protects against reperfusion-induced permeability transition, i.e., mitochondria from hyperthyroid rats, treated with OG, retained accumulated Ca(2+), similarly to control mitochondria. OG maintained post reperfusion cardiac frequency in hyperthyroid rats at 429 +/- 16 in comparison to control and T3 treated rats (70 +/- 12 and 71 +/- 2, respectively). We also found that OG diminished the post reperfusion accumulation of IFNgamma from 34.3 +/- 2.5 to 18.7 +/- 1.35, IL-6 from 38.5 +/- 4.5 to 15.1 +/- 0.12, IL-1 from 16.78 +/- 0.73 to 12.19 +/- 1.54, and TNFalpha from 45.05 +/- 3.14 to 29.85 +/- 4.3 (pg/50 microg myocardial tissue). It is concluded that OG inhibits the hypersensitivity of the hyperthyroid myocardium to undergo reperfusion damage due to its inhibitory action on the permeability transition pore.

PubMed Disclaimer

References

    1. Circulation. 2006 Jul 4;114(1 Suppl):I282-9 - PubMed
    1. Comp Biochem Physiol B Biochem Mol Biol. 2003 May;135(1):177-82 - PubMed
    1. Cardiovasc Res. 2004 Feb 15;61(3):372-85 - PubMed
    1. Eur J Endocrinol. 1997 Mar;136(3):231-9 - PubMed
    1. Shock. 2000 Aug;14(2):144-9 - PubMed

MeSH terms